BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24656736)

  • 1. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
    Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
    J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
    Kim TG; Jin KH; Kang J
    Int Ophthalmol; 2019 Jan; 39(1):21-31. PubMed ID: 29274021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome.
    Mejico LJ; Miller NR; Dong LM
    Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
    Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
    Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.
    Gedik S; Gur S; Atalay B; Colak M; Altinors N; Akova YA
    Saudi Med J; 2007 Sep; 28(9):1380-4. PubMed ID: 17768464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional assessment before and after interventions on the optic chiasm system].
    Menke E; Osarovsky E; Reitner A; Matula C
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):33-7. PubMed ID: 12407933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of optical coherence tomography in the detection of pituitary adenoma.
    Johansson C; Lindblom B
    Acta Ophthalmol; 2009 Nov; 87(7):776-9. PubMed ID: 18771481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968-1987.
    Sullivan LJ; O'Day J; McNeill P
    J Clin Neuroophthalmol; 1991 Dec; 11(4):262-7. PubMed ID: 1838546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision-related quality of life in patients with pituitary adenoma.
    Okamoto Y; Okamoto F; Hiraoka T; Yamada S; Oshika T
    Am J Ophthalmol; 2008 Aug; 146(2):318-322. PubMed ID: 18538298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of visual loss associated with pituitary macroadenomas.
    Poon A; McNeill P; Harper A; O'Day J
    Aust N Z J Ophthalmol; 1995 May; 23(2):107-15. PubMed ID: 7546685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy.
    Lee S; Kim SJ; Yu YS; Kim YH; Paek SH; Kim DG; Jung HW
    Br J Neurosurg; 2013 Aug; 27(4):425-9. PubMed ID: 23421587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual outcome of surgically managed pituitary adenomas followed-up at the Yaoundé Central Hospital.
    Njami VA; Epee E; Nguifo Fongang EJ; Bello F; Ekoumelon R; Bukam ED; Sobngwi E; Djientcheu VP
    Br J Neurosurg; 2018 Oct; 32(5):521-527. PubMed ID: 30073855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adenoma of the pituitary gland in the ophthalmologist's out-patient practice].
    Kochánová I; Stasek A; Kubena T
    Cesk Slov Oftalmol; 2004 Sep; 60(5):348-55. PubMed ID: 15566223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
    Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
    AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual field defects in non-functioning pituitary adenomas.
    Thomas R; Shenoy K; Seshadri MS; Muliyil J; Rao A; Paul P
    Indian J Ophthalmol; 2002 Jun; 50(2):127-30. PubMed ID: 12194569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
    Monteiro ML; Zambon BK; Cunha LP
    Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis in visual field defects of glaucoma patients].
    Brunotte I; Haubitz B; Winter R; Meyer MW
    Klin Monbl Augenheilkd; 2008 Feb; 225(2):169-72. PubMed ID: 18293271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic nerve hyperintensity on T2-weighted images among patients with pituitary macroadenoma: correlation with visual impairment.
    Tokumaru AM; Sakata I; Terada H; Kosuda S; Nawashiro H; Yoshii M
    AJNR Am J Neuroradiol; 2006 Feb; 27(2):250-4. PubMed ID: 16484385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field improvement after pituitary tumor surgery in patients with McCune-Albright syndrome.
    Ma J; Zhao C; Wang R; Feng F; Wang E; You H; Jiang Y; Zhang M; Zhong Y
    J Neuroophthalmol; 2013 Mar; 33(1):26-9. PubMed ID: 23222370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The volume of tumor mass and visual field defect in patients with pituitary macroadenoma.
    Lee JP; Park IW; Chung YS
    Korean J Ophthalmol; 2011 Feb; 25(1):37-41. PubMed ID: 21350693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.